The electronic Common Technical Document has been the global standard for pharma dossier management for over two decades. Most organisations built their workflows around eCTD 3.2.2 and moved on. In 2026, three developments are forcing
Read More
If you have ever sat across a regulatory team trying to prepare simultaneous dossiers for the US FDA, EMA, and CDSCO, you already know the feeling. It is not just about assembling data. It is
Read More
Regulatory affairs has never exactly been a slow moving field. But 2026 feels different. Agencies that spent years cautiously watching AI from a distance are now actively deploying it. Real world evidence once a nice
Read More
Given the abundance of connected devices, cloud-linked systems, software-driven platforms, and their ability to pose direct risks to patient safety, data integrity, and product reliability, Cybersecurity has now become more than a compliance issue. From
Read MoreIndia’s pharmaceutical market continues to expand, and with the growth comes greater responsibility for drug safety oversight. The Central Drugs Standard Control Organization (CDSCO) plays a central role in shaping the country’s pharmacovigilance framework. Key
Read MoreIndia’s pharmaceutical sector is evolving from high-volume output to strategic global importance. The domestic market, currently USD 50–60 billion, is projected to reach USD 130 billion by 2030. With FY2026 growth forecasts of 7%–11%, India
Read MoreMOH interaction and health authority liaison have become critical differentiators for medical device manufacturers navigating diverse, regulated, and fast-evolving regulatory landscapes. Every country’s Ministry of Health (MOH) or equivalent health agency expects precise documentation, consistent
Read MoreGlobally, Pharmacovigilance (PV) is built on one central idea: the benefit–risk evaluation should not stop at approval; it must continue through the full drug development regulatory process and the product’s commercial lifecycle. It is no
Read MoreIdeating, researching, and developing a drug or biologic product and bringing it to market is not a simple process. From preclinical discovery through market authorization, every stage of the drug lifecycle is critical. Across the
Read More
Are you a medical device manufacturer working on digital therapeutics, remote monitoring tools, or AI-enabled care solutions for chronic disease management? If your innovation is outcome-based and driven by real-world data, you should pay close
Read More